Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Total Assets
Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) holds total assets worth CN¥2.80 Billion CNY (≈ $409.67 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check total reinvestment intensity of Shandong Bailong Chuangyuan Bio-Tech Co. to assess the company's total reinvestment commitment from operating cash flow.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Total Assets Trend (2016–2025)
This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total assets have evolved over time, based on quarterly financial data. Check 605016 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2025)
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total assets of CN¥2.80 Billion consist of 46.6% current assets and 53.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 20.6% |
| Accounts Receivable | CN¥294.97 Million | 12.1% |
| Inventory | CN¥287.39 Million | 11.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥16.35 Million | 0.7% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Shandong Bailong Chuangyuan Bio-Tech Co. market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s current assets represent 46.6% of total assets in 2025, a decrease from 50.1% in 2016.
- Cash Position: Cash and equivalents constituted 20.6% of total assets in 2025, down from 26.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 12.1% of total assets.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Total Assets
Key competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF127.15 Billion |
|
JBS N.V.
NYSE:JBS
|
USA | $248.34 Billion |
|
MEIJI HLD.UN.ADR 1/4 O.N.
F:3M00
|
Germany | €1.23 Trillion |
|
CSPC Innovation Pharmaceutical Co Ltd Class A
SHE:300765
|
China | CN¥6.21 Billion |
|
ORKLA ADR/1 NK 625
F:OKL0
|
Germany | €88.70 Billion |
|
Tingyi (Cayman Islands) Holding Corp
F:TYG
|
Germany | €54.94 Billion |
|
Yantai China Pet Foods Co Ltd
SHE:002891
|
China | CN¥6.24 Billion |
|
Yihai International Holding Ltd
F:YIR
|
Germany | €5.36 Billion |
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.51 | 2.72 | 7.51 |
| Quick Ratio | 1.97 | 2.16 | 6.63 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥843.60 Million | CN¥663.99 Million | CN¥711.16 Million |
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.63 |
| Latest Market Cap to Assets Ratio | 0.63 |
| Asset Growth Rate (YoY) | 21.0% |
| Total Assets | CN¥2.44 Billion |
| Market Capitalization | $1.55 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s assets below their book value (0.63x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s assets grew by 21.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
The table below shows the annual total assets of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.44 Billion ≈ $356.56 Million |
+21.02% |
| 2024-12-31 | CN¥2.01 Billion ≈ $294.64 Million |
+14.78% |
| 2023-12-31 | CN¥1.75 Billion ≈ $256.69 Million |
+19.17% |
| 2022-12-31 | CN¥1.47 Billion ≈ $215.39 Million |
+14.77% |
| 2021-12-31 | CN¥1.28 Billion ≈ $187.67 Million |
+53.41% |
| 2020-12-31 | CN¥836.00 Million ≈ $122.33 Million |
+10.82% |
| 2019-12-31 | CN¥754.35 Million ≈ $110.38 Million |
+23.70% |
| 2018-12-31 | CN¥609.80 Million ≈ $89.23 Million |
-2.55% |
| 2017-12-31 | CN¥625.78 Million ≈ $91.57 Million |
-0.95% |
| 2016-12-31 | CN¥631.82 Million ≈ $92.45 Million |
-- |
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more